Digital health company Klue announced this week that its latest AI-driven software is a module designed for people with Type I diabetes.
The technology features autonomous meal detection capabilities and provides mealtime medication reminders to users, according to the San Francisco, Calif.-based company.
The module, which works with hardware like the Apple Watch, also provides automated text messaging for caregivers. Klue noted that its software can be integrated into third-party apps.
People with Type I diabetes can access the new bolus reminder module in the Klue Health App for the Apple Watch ahead of its launch, according to Klue, by signing up for trial spots.
“We are here to help people live healthier and happier lives. We believe that the future of healthcare delivery will thrive on personal, in-the-moment interactions centered around times of high impact,” Klue’s founder & CEO, Katelijn Vleugels, said in prepared remarks. “The introduction of a reminder module for mealtime insulin administration is another important step in the realization of that vision.”
“I am excited about the potential of Klue’s early meal detection capabilities to advance Type 1 diabetes research and reduce the burden of diabetes,” Dr. Marc Breton, professor at the UVA Center for Diabetes Technology, added. “Missed pre-meal insulin boluses are a leading contributor to poor glycemic control and Klue’s real-time detection could be beneficial to many people with type 1 diabetes. I am most excited about the prospect of using Klue’s technology within a fully autonomous closed-loop artificial pancreas system. Automated real-time information of a patient’s eating behavior, coupled with novel control algorithms, may very well enable a true ‘set and forget’ closed loop insulin delivery system.”
Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.